Position in HALO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,215,140
+$248,664 QoQ
Shares Held
15,525
+3.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#293
of 661 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOKF, NA holds $13,252,747 across 20 Biotechnology names. HALO ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,560 | $3,258,548 | |
| 2 | EXEL |
Exelixis, Inc.
|
55,213 | $3,004,138 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
23,938 | $2,081,408 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
15,525 | $1,215,140 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,346 | $839,284 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
15,306 | $598,770 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
1,573 | $584,636 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
13,904 | $506,244 |
All Filings in HALO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,215,140 | 15,525 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $966,476 | 14,954 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,080,164 | 16,050 | Shares | Sole | 2026-02-03 | |
| 2025-06-30 | $780 | 15 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $494,782 | 7,754 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,781 | 100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,266 | 92 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,817 | 92 | Shares | Sole | 2024-08-08 | |
| 2022-12-31 | $200,970 | 3,532 | Shares | Other | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||